ARTICLE | Clinical News
Glumetza metformin regulatory update
June 6, 2005 7:00 AM UTC
FDA approved Glumetza 500 mg and 1,000 mg once-daily extended release formulations of metformin to treat Type II diabetes. In April, BVF and DEPO submitted a complete response to FDA to address one ma...